Yep, the pandemic is totally over…which is why I can’t keep Enovid nasal spray and clinical strength mouthwash with CPC (both used to reduce viral loads at the source) in the house. I keep giving it away to friends and family with known exposures or who have tested pos for #covid
🐦 📎 https://twitter.com/ibjiyongi/status/1637947168702054401?s=61&t=s8HukwH5qKCMfvWu6u8QfA
Make every day #LongCovidAwarenessDay @loscharlos calls us to action in this 🧵 🔥
🐦🔗 https://twitter.com/loscharlos/status/1636085372215259137?s=61&t=s8HukwH5qKCMfvWu6u8QfA
The current vaccine-only approach focused on blunting the severity of COVID-19 isn’t working.
We need next Gen intranasal vaccines that build mucosal immunity and prevent transmission at the source.
What does 2023 have in store for next gen vaccines? #covid
https://www.cbsnews.com/news/covid-19-vaccines-nasal-sprays-pills-breakthroughs-2023/
Pivotal results on a variety of next generation approaches are expected soon, as a panel of FDA advisers is set to weigh the future of immunization against SARS-CoV-2.
The debate over the origin of the 🦠 suffers from an absence of hard evidence and an abundance of confirmation bias.
It’s distracting us from what we urgently need to do—slow transmission, develop sterilizing intranasal vaccines, and find ways to prevent and treat #LongCovid #covid
Bivalent boosters wane at 4-5 months, and many are now 6 months out from their 💉. Going forward, the plan appears to be 1 dose/per year for everyone.
Is there any empirical evidence against allowing those 65+, immunocompromised, or anyone else to get another bivalent booster?